ArticleCell communication and signaling : CCS2026
Paternal Sertoli cell-derived extracellular vesicles transfer mtDNA and microRNA cargo to trigger germ cell oxidative stress and induce metabolic risks in offspring.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
While obesity causes male infertility through testicular lipid stress, the mechanisms by which this stress alters Sertoli cell-derived extracellular vesicles (EVs) to induce paternal reproductive defects and offspring metabolic dysfunction remain unclear. Here, we report that lipid-overloaded Sertoli cells release modified EVs that impair paternal reproductive health and predispose offspring to metabolic disorders. Specifically, we found that palmitic acid treatment alters the lipid composition of Sertoli-derived EVs, resulting in an elevated phosphatidylethanolamine (PE)/phosphatidylcholine (PC) ratio that facilitates their uptake by spermatogonia. Omics sequencing revealed that lipid-overloaded Sertoli cells secreted mitochondrial-rich EVs containing mitochondrial DNA (mtDNA) and miR-6240, induced oxidative stress and repressed Creb1/Crem in recipient germ cells. In vivo, injection these PA-EVs impaired spermatogenesis, resulting in a 21.87% reduction in sperm density. Notably, paternal exposure to these modified EVs induced adverse outcomes in F1 offspring. F1 male offspring exhibited developmental retardation and increased susceptibility to metabolic syndrome, characterized by severe hepatic steatosis under a high-fat diet challenge. Mechanistically, this inherited predisposition was driven by a reprogramming of hepatic lipid metabolism, as multi-omics analysis revealed a significant upregulation of genes critical for fatty acid uptake and metabolism. Collectively, our findings demonstrate that Sertoli cell-derived EVs serve as mediators of paternal effects on offspring metabolic health, highlighting a potential therapeutic target to mitigate obesity-related infertility and prevent metabolic dysfunction in offspring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.